Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids

OBJECTIVES: To investigate the efficacy and safety of trimethoprim/sulfamethoxazole (TMP-SMX) as primary prophylaxis for pneumocystis pneumonia (PCP) in patients with rheumatic diseases receiving high-dose steroids. METHODS: The study included 1522 treatment episodes with prolonged (≥4 weeks) high-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jun Won, Curtis, Jeffrey R, Moon, Jinyoung, Song, Yeong Wook, Kim, Suhnggwon, Lee, Eun Bong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909751/
https://www.ncbi.nlm.nih.gov/pubmed/29092853
http://dx.doi.org/10.1136/annrheumdis-2017-211796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909751/
https://www.ncbi.nlm.nih.gov/pubmed/29092853
http://dx.doi.org/10.1136/annrheumdis-2017-211796

Ejemplares similares